Latest Partnerships News

Artrya Limited reported a 17.2% increase in net loss to $16.4 million for FY25, while achieving FDA clearance and launching its AI-driven Salix platform in the U.S. market. The company also secured key commercial partnerships in Australia and raised $20 million in equity funding.

Euroz Hartleys Group Limited reported a robust 87.7% increase in net profit for FY25, driven by growth across brokerage, underwriting, and wealth management. The company declared a fully franked full-year dividend of 5.5 cents per share, reflecting confidence in its operational leverage and balance sheet strength.

Alliance Aviation Services reported record flying hours and strong revenue growth in FY25, while statutory profit dipped slightly amid operational challenges.

Harmoney has delivered a robust FY25 performance, exceeding its upgraded profit guidance with strong loan book growth and improved efficiency. The fintech lender projects a remarkable 111% increase in cash NPAT for FY26, driven by its AI-powered Stellare 2.0 platform and strategic expansion plans.

Straker Ltd reported a 10% revenue decline in FY25 but achieved record gross margins and adjusted EBITDA, underscoring its strategic shift to AI-driven language services and expanding IBM partnership.

Genetic Technologies Limited has emerged from voluntary administration following a strategic asset sale and is now pursuing recapitalisation and acquisitions to restore its market position.

Redcastle Resources Limited has resumed trading on the ASX following key announcements about a joint venture farm-out, a strategic placement, and a major gold project acquisition.

Redcastle Resources has partnered with BML Ventures to fast-track gold production at key deposits while massively expanding its Eastern Goldfields footprint through a strategic tenement acquisition.

Genetic Technologies Limited reports a 36% increase in half-year losses amid voluntary administration, followed by a recapitalisation and sale of core assets. The company pivots towards new financial services acquisitions under fresh leadership.

WOTSO’s FY25 results reveal a robust 14% increase in underlying EBITDA, driven by its expanding flexible workspace portfolio now spanning 31 locations. Strategic investments and partnerships underpin a confident outlook toward $58 million revenue by FY30.

Invion Limited secures a pivotal FDA Orphan Drug Designation for its lead candidate INV043, targeting anal cancer with promising preclinical results and a fast-tracked development path.

FirstWave Cloud Technology is launching its first AI-powered compliance management feature for Open-AudIT, aiming to convert a large base of free users into paying customers through a subscription model integrated with AWS.